LRRK2-IN-2 (化合物 22) 是一种有效,选择性,具有口服活性和可透过血脑屏障的LRRK2抑制剂,IC50值为 0.6 nM。LRRK2-IN-2 可用于帕金森氏病的研究。
半岛bd体育手机客户端 描述
LRRK2-IN-2 (compoubd 22) is a potent, selective, orally active and brain-penetrant inhibitor LRRK2, with IC 50 of<0.6 nM. LRRK2-IN-2 can be used for the research of Parkinson's disease [1].
Cas No.
2641059-19-8
分子式
C23H23Cl2F3N6O2
分子量
543.37
储存和溶解度
(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years